The following are my published articles in international journals.
MY PUBLICATIONS I
1]
Abbas FM, Julie BM, Sharma A, Halawa A. “Contrast
nephropathy” in renal transplantation: Is it real? World J
Transplant 2016; 6 (4): 682-688 https://www.wjgnet.com/2220-3230/full/v6/i4/682.htm
Summery: One of the greatest risks on the human kidney is the exposure of
the human kidney to the contrast material. This risk will be augmented in the
presence of diabetes mellitus and dehydration. Many therapeutic options have
been suggested, but unfortunately, the optimum option still uncertain.
2] Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases? World J Transplant 2017; 7(6): 285-300
https://www.wjgnet.com/2220-3230/full/v7/i6/285.htm
Summary: With the presence of good history in the preparation of a kidney transplant, we can diagnose that this disease that affecting the implanted graft is a new one i.e. de novo GN (glomerular) disease. This is to a great extent depends on the presence of enough data documenting the absence of any data related to the new GN disease.
3] Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. Recurrence of primary glomerulonephritis: Review of the current evidence. World J Transplant 2017; 7(6): 301-316 https://dx.doi.org/10.5500/wjt.v7.i6.301
Summery: Kidney transplantation has been approved as the best therapeutic option for ESRD (end stage renal disease). Unfortunately, the risk of recurrence of the native kidney disease is a major risk for failure of the new implanted graft. The list of recurrent kidney diseases has been discussed. Not all the kidney diseases are vulnerable for recurrence and the therapeutic approach of these recurrent diseases will be slightly different.
4]
Abbas
F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy
after renal transplantation: Current insights in de novo and recurrent
disease. World J Transplantation 2018; 8(5):
122-141 https://www.wjgnet.com/2220-3230/full/v8/i5/122.htm
Summary: Thrombotic microangiopathy (TMA) is a serious disease endangering
the survival of the kidney allograft. Early recognition of this disease is
mandated for a better TMA management. The role genetic studies have been
recently elucidated. The recently admitted, complement blocker agents has been
approved to play a fundamental role of this devastating disease. This will be definitely
reflected on the kidney allograft longevity.
5] Abbas F, El Kossi M, Kim JJ, Shaheen IS, Sharma A, Halawa A. Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in de novo and recurrent diseases. World J Transplantation 2018; 8(6): 203-219 https://www.wjgnet.com/2220-3230/full/v8/i6/203.htm
Summary: The advent of complement blocker agents has been clearly successful
in the control of serious and resistant diseases that could be attributed to
many genetic mutations (alterations). The observed benefits of these curative
agents not only curative for these group of diseases but also have a preventive
role against post-transplant recurrence of complement-related diseases.
6]
Fedaey
Abbas, Mohsen El Kossi, Jon Jin Kim, Ihab Sakr
Shaheen, Ajay Sharma, Ravi Pararajasingam and Ahmed Halawa. Management of Diabetic Patient with CKD 5 and Progressive Diabetic
Complications: A Case-Based Review. World
Journal of Transplantation. J of Transplantation science.
Summary: Diabetes mellitus is a vascular disease.
Old-standing diabetic patients are vulnerable for many complications, particularly
so, in poorly controlled diabetic patients. An offered pancreatic graft life
span up to 14 years, this lady- in our case- can gain a double benefit of SKP
(simultaneous Kidney-pancreatic) transplantation. However, in view of the
current shortage of a cadaveric donor transplant, an offered living related
donor kidney would be a reasonable therapeutic choice in absence of a direct
contraindication. On the other hand, PAK (pancreatic after kidney) transplant
as well as Islets after kidney transplant may be an alternate approach.
However, pancreatic alone or Islets transplant alone would be inappropriate
options owing to the possibility of developed sensitivity. The latter might
impede any future chance of transplantation.
7] Abbas
F, El Kossi M, Kim JJ, Shaheen IS, Sharma A, Pararajasingam R, Halawa A. Parasitic
infestation in organ transplant recipients: a comprehensive review in the
absence of robust evidence. J Egypt Soc Nephrol Transplant [serial
online] 2019 [cited 2019 Jun 12]; 19:31-61. Available from: http://www.jesnt.eg.
net/text. asp? 2019/19/2/31/260214
Summary: In
view of the widespread extension of organ transplant centres all over the world
and the expansion of transplant tourism, the possibility of transmission of
parasitic infection is currently increasing. Furthermore, awareness of this
type of infection is gaining more interest. Some of these parasites are related
to endemic infestation, while other are more related to the source of donation,
i.e. the donated organ. The recent progress, however, in diagnosing these types
of infestations as well as the advancement in serology and microbiology may allow
limitations of the possibility of parasitic transmission whatever the source
originating from. Both the transplant recipient and his/her clinician should be
aware of this unique type of infection.
8] Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World J Transplant 2020; 10(2): 29-46. https://www.wjgnet.com/2220-3230/full/v10/i2/29.ht 10.5500/ wjt.v10.i2.29
Summary:
One of the most serious complications after kidney transplantation is the
development of malignancy of the lymphatic system. An augmented immunosuppressive
load is usually the culprit agent. Moreover, re-transplantation can be- despite
rare- associated with recurrence of this type of malignancy. The recent
progress on genomic technology has its impact of this serious disease. An
increased awareness of the manifestations of this complication is necessary for
a timely diagnosis and proper management. Furthermore, close liaison between
nephrology and hemato-oncology teams will be reflected on the better control of
this type of cancer.
9] Books: My first “book”: “Seven Hundred Questions and Answers in Nephrology, Dialysis and Transplantation: “794” Questions with model answers in Clinical Nephrology, Dialysis and Transplantation, 400 pages enriched with many histopathologic slides and radiographic pictures were supplied. The book is dealing with various clinical problems in clinical nephrology, hemodialysis and kidney transplantation associated with model answers. (مكتبة "المريخ"- جده والرياض KSA"(.
10] Second
book,
(in press): “Renal Face”
clinical scenarios for diagnosis of kidney diseases via checking facial lesions in a patient with kidney
disease.
{With Prof Dr “Abdol Majid Nahass”, Sheffield, UK}.
Congratulations Dr/Fedaey
ReplyDeleteThx toiushe, any more contact information, which country, please
Delete